1. Home
  2. NRGV vs ABCL Comparison

NRGV vs ABCL Comparison

Compare NRGV & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Vault Holdings Inc.

NRGV

Energy Vault Holdings Inc.

HOLD

Current Price

$4.49

Market Cap

912.8M

Sector

Miscellaneous

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.24

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRGV
ABCL
Founded
2017
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
912.8M
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NRGV
ABCL
Price
$4.49
$3.24
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
$1.75
$7.75
AVG Volume (30 Days)
2.7M
4.9M
Earning Date
03-16-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$83,836,000.00
$35,325,000.00
Revenue This Year
$322.22
$25.45
Revenue Next Year
$29.01
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.17
52 Week Low
$0.60
$1.89
52 Week High
$6.35
$6.52

Technical Indicators

Market Signals
Indicator
NRGV
ABCL
Relative Strength Index (RSI) 40.96 33.59
Support Level $5.08 $3.92
Resistance Level $5.47 $3.69
Average True Range (ATR) 0.49 0.28
MACD -0.15 -0.11
Stochastic Oscillator 15.72 5.09

Price Performance

Historical Comparison
NRGV
ABCL

About NRGV Energy Vault Holdings Inc.

Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: